245 related articles for article (PubMed ID: 16330935)
21. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.
Yao DX; Shia J; Erlandson RA; Klimstra DS
Ultrastruct Pathol; 2004; 28(4):213-28. PubMed ID: 15693633
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.
Foster MR; Johnson JE; Olson SJ; Allred DC
Arch Pathol Lab Med; 2001 Oct; 125(10):1316-20. PubMed ID: 11570906
[TBL] [Abstract][Full Text] [Related]
23. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.
Abutaily AS; Addis BJ; Roche WR
J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
[TBL] [Abstract][Full Text] [Related]
26. Malignant Para-Testicular Mesothelioma: A Rare Presentation in the Tunica Vaginalis of an Elderly Male With No Prior Asbestos Exposure.
Shaker N; Blankenship H; Shaker N; Ben Musa R; Niu S; Alrohaibani A; Mansoor I; Abu Shakra R; Sangueza OP
Int J Surg Pathol; 2024 Jan; ():10668969231215426. PubMed ID: 38166430
[TBL] [Abstract][Full Text] [Related]
27. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
28. Primary malignant gonadal mesotheliomas and asbestos.
Attanoos RL; Gibbs AR
Histopathology; 2000 Aug; 37(2):150-9. PubMed ID: 10931239
[TBL] [Abstract][Full Text] [Related]
29. Malignant mesothelioma of the tunica vaginalis.
Kamiya M; Eimoto T
Pathol Res Pract; 1990 Oct; 186(5):680-4; discussion 685-6. PubMed ID: 2287593
[TBL] [Abstract][Full Text] [Related]
30. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
31. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
Brown RW; Clark GM; Tandon AK; Allred DC
Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
[TBL] [Abstract][Full Text] [Related]
32. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
Dejmek A; Hjerpe A
Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
[TBL] [Abstract][Full Text] [Related]
33. Primary malignant mesothelioma of the tunica vaginalis of the testis. Immunohistochemistry and electron microscopy.
Berti E; Schiaffino E; Minervini MS; Longo G; Schmid C
Pathology; 1997 Feb; 29(1):96-9. PubMed ID: 9094189
[TBL] [Abstract][Full Text] [Related]
34. Papillary mesothelioma of the tunica vaginalis propria testis. Case report and ultrastructural study.
Mikuz G; Höpfel-Kreiner I
Virchows Arch A Pathol Anat Histol; 1982; 396(2):231-8. PubMed ID: 7123851
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the Rete Testis: Clinicopathologic and Immunohistochemical Characterization of 6 Cases and Review of the Literature.
Al-Obaidy KI; Idrees MT; Grignon DJ; Ulbright TM
Am J Surg Pathol; 2019 May; 43(5):670-681. PubMed ID: 30676333
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
[TBL] [Abstract][Full Text] [Related]
37. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
Hammar SP; Bockus DE; Remington FL; Rohrbach KA
Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression.
Bateman AC; al-Talib RK; Newman T; Williams JH; Herbert A
Histopathology; 1997 Jan; 30(1):49-56. PubMed ID: 9023557
[TBL] [Abstract][Full Text] [Related]
39. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
40. Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature.
Shelton D; Dalal N
J Clin Pathol; 2012 Oct; 65(10):958-9. PubMed ID: 22593592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
